Correlation Between Organon and Pliant TherapeuticsInc

Can any of the company-specific risk be diversified away by investing in both Organon and Pliant TherapeuticsInc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Organon and Pliant TherapeuticsInc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Organon Co and Pliant TherapeuticsInc, you can compare the effects of market volatilities on Organon and Pliant TherapeuticsInc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Organon with a short position of Pliant TherapeuticsInc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Organon and Pliant TherapeuticsInc.

Diversification Opportunities for Organon and Pliant TherapeuticsInc

-0.22

Correlation Coefficient

Organon  Pliant TherapeuticsInc

Very good diversification

The 3 months correlation between Organon and Pliant is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Organon Co and Pliant TherapeuticsInc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant TherapeuticsInc and Organon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Organon Co are associated (or correlated) with Pliant TherapeuticsInc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant TherapeuticsInc has no effect on the direction of Organon i.e., Organon and Pliant TherapeuticsInc go up and down completely randomly.

Pair Corralation between Organon and Pliant TherapeuticsInc

Considering the 90-day investment horizon Organon Co is expected to generate 0.48 times more return on investment than Pliant TherapeuticsInc. However, Organon Co is 2.07 times less risky than Pliant TherapeuticsInc. It trades about 0.57 of its potential returns per unit of risk. Pliant TherapeuticsInc is currently generating about 0.26 per unit of risk. If you would invest  1,763  in Organon Co on February 17, 2024 and sell it today you would earn a total of  424.00  from holding Organon Co or generate 24.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Organon Co  vs.  Pliant TherapeuticsInc

Organon

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Organon Co are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, Organon displayed solid returns over the last few months and may actually be approaching a breakup point.

Pliant TherapeuticsInc

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Pliant TherapeuticsInc are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Pliant TherapeuticsInc is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Organon and Pliant TherapeuticsInc

The main advantage of trading using opposite Organon and Pliant TherapeuticsInc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Organon position performs unexpectedly, Pliant TherapeuticsInc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant TherapeuticsInc will offset losses from the drop in Pliant TherapeuticsInc's long position.

The idea behind Organon Co and Pliant TherapeuticsInc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.